<ARTICLE>5 <LEGEND> Exhibit 27 for Bristol-Myers Squibb for the period ended 9/30/95 </LEGEND> <MULTIPLIER>1000000 <PERIOD-TYPE> 9-Mos <FISCAL-YEAR-END> Dec-31-1995<F1> <PERIOD-END> Sep-30-1995 <CASH> 1,674 <SECURITIES> 510 <RECEIVABLES> 2,189 <F2> <ALLOWANCES> 0 <INVENTORY> 1,438 <CURRENT-ASSETS> 6,610 <PP&E> 6,123 <DEPRECIATION> 2,333 <TOTAL-ASSETS> 13,382 <CURRENT-LIABILITIES> 4,211 <BONDS> 632 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 54 <OTHER-SE> 6,263 <TOTAL-LIABILITY-AND-EQUITY> 13,382 <SALES> 10,159 <TOTAL-REVENUES> 10,159 <CGS> 2,716 <TOTAL-COSTS> 2,716 <OTHER-EXPENSES> 4,691 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 69 <INCOME-PRETAX> 2,752 <INCOME-TAX> 798 <INCOME-CONTINUING> 1,954 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 1,954 <EPS-PRIMARY> 3.86 <EPS-DILUTED> 0 <FN> <F1> Items reported as "zero" are not applicable or are immaterial to the consolidated financial position of the Company. <F2> Receivables are reported net of allowances for doubtful accounts.